Aptamer Group seals two significant deals worth £235,000
2025-05-15 22:47:38
Life sciences firm Aptamer Group has announced two significant deals worth a combined £235,000.
The York based operator was launched on AIM in 2021 to maximise the potential of its Optimer binder technology in applications across life sciences and other industries. Its latest deal wins have seen it secure a contract valued at up to £175,000 with a top five pharmaceutical company, and a deal worth up to £60,000 with a global provider of specialty enzymes used widely throughout the life sciences sector.
As part of the first contract, Aptamer will develop Optimer
